HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki
 


Pfizer Company News

Tue, 30 Apr 2019 07:00:00 GMT
Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript - Motley Fool
<ol><li> Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript Motley Fool</font></li><li><a href="/url/?u=https://finance.yahoo.com/news/pfizer-posts-9-percent-rise-110432576.html" target="_blank">Vaccine and blood thinner help drive Pfizer to quarterly earnings beat Yahoo Finance</font></li><li><a href="/url/?u=https://www.bloomberg.com/news/articles/2019-04-30/pfizer-s-earnings-exceed-estimates-as-new-ceo-bourla-takes-reins" target="_blank">Pfizer Earnings Top Estimates as New CEO Bourla Takes Reins Bloomberg</font></li><li><a href="/url/?u=https://seekingalpha.com/article/4258082-pfizer-inc-pfe-ceo-albert-bourla-q1-2019-results-earnings-call-transcript" target="_blank">Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript Seeking Alpha</font></li><li><a href="/url/?u=https://www.kveo.com/news/business/biopharmaceuticals-power-pfizer-in-the-first-quarter/1965622451" target="_blank">Pfizer 1Q profit jumps 9% on higher drug sales, lower costs KVEO-TV</font></li><li><strong><a href="/url/?u=https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpWcGZIdmpZQU1FZWVmRF9KUGlNck5LQUFQAQ?oc=5" target="_blank">View full coverage on Google News</a></strong></li></ol>
Wed, 08 May 2019 00:21:00 GMT
Can Pfizer Leap Over the Competition With This Potential Blockbuster? - Motley Fool
Can Pfizer Leap Over the Competition With This Potential Blockbuster? Motley Fool It's been nearly seven years since the FDA refused to approve tafamidis' first new drug application, and the field is a lot more crowded now.
Thu, 09 May 2019 15:24:00 GMT
Pfizer to buy VC-backed biotech firm Therachon - PE Hub
Pfizer to buy VC-backed biotech firm Therachon PE Hub Pfizer has agreed to acquire Therachon, a biotech company focused on rare diseases, for $340 million upfront with an additional $470 million in contingent ...
Wed, 08 May 2019 17:48:45 GMT
Updated: Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names - Regulatory Focus
Updated: Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names Regulatory Focus In response to the US Food and Drug Administration's (FDA) proposal to not go back and rename certain biologics with nonsense suffixes, as it once said it ...
Tue, 07 May 2019 00:07:08 GMT
Brainstorm Health: Royal Baby, All of Us, Pfizer Heart Drug Approval - Fortune
Brainstorm Health: Royal Baby, All of Us, Pfizer Heart Drug Approval Fortune Happy Monday, readers. I hope you've had a wonderful weekend. Alright, I'll come clean up top… This sort of is about the royal baby. But only as a point of ...
Sun, 05 May 2019 11:30:00 GMT
5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term - Yahoo Finance
5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term Yahoo Finance A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.
Mon, 06 May 2019 13:08:00 GMT
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins - Yahoo Finance
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins Yahoo Finance For Immediate Release. Chicago, IL – May 6, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...
Thu, 09 May 2019 01:05:00 GMT
GSK-Pfizer deal gets approval from Australia's anti-trust watchdog - Reuters
GSK-Pfizer deal gets approval from Australia's anti-trust watchdog Reuters (Reuters) - GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business will not lesson competition in Australia, the country's anti-trust regulator said on ...
Thu, 09 May 2019 13:40:00 GMT
EuroBiotech Report—Lundbeck, Pfizer ink deals; Confo, Promethera raise cash; and Bicycle - FierceBiotech
EuroBiotech Report—Lundbeck, Pfizer ink deals; Confo, Promethera raise cash; and Bicycle FierceBiotech In this week's EuroBiotech Report, Lundbeck and Pfizer strike buyouts, Confo and Promethera raise cash and Bicycle hires staff.
Tue, 30 Apr 2019 07:00:00 GMT
Eli Lilly, Merck, and Pfizer Earnings Are Coming. Here’s What to Watch. - Barron's
Eli Lilly, Merck, and Pfizer Earnings Are Coming. Here’s What to Watch. Barron's The three big pharmaceutical companies — Eli Lilly, Merck, and Pfizer — are due to release their results on Tuesday. Although health care had a fairly good ...